SEARCH

SEARCH BY CITATION

References

  • Allende ML, Yamashita T, Proia RL (2003). G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102: 36653667.
  • Ancellin N, Hla T (1999). Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274: 1899719002.
  • Bernatchez PN, Tremblay F, Rollin S, Neagoe PE, Sirois MG (2003). Sphingosine 1-phosphate effect on endothelial cell PAF synthesis: role in cellular migration. J Cell Biochem 90: 719731.
  • Biswas K, Yoshioka K, Asanuma K, Okamoto Y, Takuwa N, Sasaki T, et al. (2013). Essential role of class II phosphatidylinositol-3-kinase-C2alpha in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells. J Biol Chem 288: 23252339.
  • Blaho VA, Hla T (2011). Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chem Rev 111: 62996320.
  • Cho KR, Choi JS, Hahn W, Kim DS, Park JS, Lee DS, et al. (2008). Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Eur J Cardiothorac Surg 34: 857863.
  • Gaengel K, Niaudet C, Hagikura K, Lavina B, Muhl L, Hofmann JJ, et al. (2012). The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev Cell 23: 587599.
  • Gonzalez E, Kou R, Michel T (2006). Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. J Biol Chem 281: 32103216.
  • Igarashi J, Michel T (2001). Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways. J Biol Chem 276: 3628136288.
  • Igarashi J, Bernier SG, Michel T (2001). Sphingosine 1-phosphate and activation of endothelial nitric oxide synthase: differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276: 1242012426.
  • Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H (2007). Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator. Am J Physiol Cell Physiol 292: C740C748.
  • Igarashi J, Shoji K, Hashimoto T, Moriue T, Yoneda K, Takamura T, et al. (2009). Transforming growth factor-beta1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells. Am J Physiol Cell Physiol 297: C1263C1274.
  • Igarashi J, Hashimoto T, Shoji K, Yoneda K, Tsukamoto I, Moriue T, et al. (2013). Dexamethasone induces caveolin-1 in vascular endothelial cells: implications for attenuated responses to VEGF. Am J Physiol Cell Physiol 304: C790C800.
  • Ishizawar R, Parsons SJ (2004). c-Src and cooperating partners in human cancer. Cancer Cell 6: 209214.
  • Kon J, Sato K, Watanabe T, Tomura H, Kuwabara A, Kimura T, et al. (1999). Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J Biol Chem 274: 2394023947.
  • Means CK, Brown JH (2009). Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc Res 82: 193200.
  • Means CK, Miyamoto S, Chun J, Brown JH (2008). S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses. J Biol Chem 283: 1195411963.
  • Muller CE, Jacobson KA (2011). Xanthines as adenosine receptor antagonists. Handb Exp Pharmacol 200: 151199.
  • Muraki K, Imaizumi Y (2001). A novel function of sphingosine 1-phosphate to activate a non-selective cation channel in human endothelial cells. J Physiol 537: 431441.
  • Murata N, Sato K, Kon J, Tomura H, Okajima F (2000). Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal Biochem 282: 115120.
  • Okabe N, Nakamura E, Himi N, Narita K, Tsukamoto I, Maruyama T, et al. (2013). Delayed administration of the nucleic acid analog 2Cl-C.OXT-A attenuates brain damage and enhances functional recovery after ischemic stroke. Brain Res 1506: 115131.
  • Okamoto H, Takuwa N, Gonda K, Okazaki H, Chang K, Yatomi Y, et al. (1998). EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J Biol Chem 273: 2710427110.
  • Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, et al. (2007). Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282: 90829089.
  • Rikitake Y, Hirata K, Kawashima S, Ozaki M, Takahashi T, Ogawa W, et al. (2002). Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. Arterioscler Thromb Vasc Biol 22: 108114.
  • Sanada Y, Mizushima T, Kai Y, Nishimura J, Hagiya H, Kurata H, et al. (2004). Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS One 6: e23933.
  • Shen J, DiCorleto PE (2008). ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 102: 448456.
  • Silvestre JS (2012). Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases. Thromb Res 130(Suppl. 1): S90S94.
  • Singh P, Singh IN, Mondal SC, Singh L, Garg VK (2013). Platelet-activating factor (PAF)-antagonists of natural origin. Fitoterapia 84: 180201.
  • Takahashi T, Ueno H, Shibuya M (1999). VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18: 22212230.
  • Tsukamoto I, Sakakibara N, Maruyama T, Igarashi J, Kosaka H, Kubota Y, et al. (2010). A novel nucleic acid analogue shows strong angiogenic activity. Biochem Biophys Res Commun 399: 699704.
  • Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, et al. (2009). Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 19: 461468.
  • Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, et al. (2008). Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102: 669676.
  • Voogd TE, Vansterkenburg EL, Wilting J, Janssen LH (1993). Recent research on the biological activity of suramin. Pharmacol Rev 45: 177203.
  • Yonesu K, Kawase Y, Inoue T, Takagi N, Tsuchida J, Takuwa Y, et al. (2009). Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. Biochem Pharmacol 77: 10111020.
  • Yoon CM, Hong BS, Moon HG, Lim S, Suh PG, Kim YK, et al. (2008). Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood 112: 11291138.